封面
市场调查报告书
商品编码
1654002

硫辛酸市场规模、份额和成长分析(按产品类型、产品形式、分销管道、应用和地区)-产业预测(2025-2032 年)

Alpha Lipoic Acid Market Size, Share, and Growth Analysis, By Product Type (R Alpha Lipoic Acid, S Alpha Lipoic Acid), By Product Form (Powder, Capsules), By Distribution Channel, By Application, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到 2023 年,硫辛酸市场规模将达到 9.103 亿美元,从 2024 年的 9.6856 亿美元成长到 2032 年的 15.9096 亿美元,预测期内(2025-2032 年)的复合年增长率为 6.4%。

硫辛酸 (ALA) 因其在能量产生和防止氧化压力方面具有众多健康益处而受到世界各地欢迎。由于 ALA 是一种天然物质,因此可以从多种食物中获取,也可以作为膳食补充剂服用。市场成长的动力来自消费者对天然补充剂的兴趣日益浓厚、对更健康生活方式的追求以及新研究强调了 ALA 对各种健康状况的有效性。 ALA 因其对皮肤健康的益处、潜在减少氧化压力和支持葡萄糖代谢而闻名,它因具有脂溶性和水溶性抗氧化剂的双重作用而脱颖而出。 ALA 有多种形式,包括液体、锭剂和胶囊,既可以作为独立产品出售,也可以以多种成分组合配方出售,以针对特定的健康问题。

目录

介绍

  • 调查目的
  • 研究范围
  • 定义

调查方法

  • 资讯采购
  • 次要和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024 年)
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析

硫辛酸市场规模(依产品类型和复合年增长率) (2025-2032)

  • 市场概况
  • R-硫辛酸
  • S-硫辛酸

硫辛酸市场规模(依产品类型和复合年增长率) (2025-2032)

  • 市场概况
  • 粉末
  • 胶囊
  • 药片
  • 其他的

硫辛酸市场规模(按分销管道和复合年增长率) (2025-2032)

  • 市场概况
  • 直接销售
  • 间接销售
  • 超级市场
  • 百货公司
  • 零售商
  • 其他的

硫辛酸市场规模(按应用和复合年增长率) (2025-2032)

  • 市场概况
  • 营养补充品
  • 化妆品
  • 药品
  • 其他的

硫辛酸市场规模及复合年增长率(2025-2032)

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲国家
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前 5 家公司对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采用的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024 年)
  • 主要企业简介
    • 公司详细信息
    • 产品系列分析
    • 公司分部份额分析
    • 收益与前一年同期比较对比(2022-2024 年)

主要企业简介

  • NNB 营养公司 (美国)
  • Avanscure Lifesciences(印度)
  • 江苏同和药业有限公司 (中国)
  • 苏州富士莱药业有限公司 (中国)
  • Cachet Pharmaceuticals Pvt. Ltd.(印度)
  • Biocon 有限公司 (印度)
  • Woerwag Pharma GmbH & Co. KG(德国)
  • 同和(中国)
  • 现代汽车(中国)
  • 福仕来药业(中国)
  • 麦德森(中国)
  • 泰科生物(中国)
  • 迪凯源科技(中国)
  • 浩翔生物(中国)
  • Infa集团(义大利)
  • Sudarshan Pharma(印度)
  • 优质补充剂製造公司(美国)
  • Supreem Pharmaceuticals Mysore Pvt. Ltd.(印度)
  • Valence Labs(印度)
  • 西安光远生物科技(中国)

结论和建议

简介目录
Product Code: SQMIG35J2082

Alpha Lipoic Acid Market size was valued at USD 910.3 million in 2023 and is poised to grow from USD 968.56 million in 2024 to USD 1590.96 million by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).

Alpha lipoic acid (ALA) is gaining global popularity due to its numerous health benefits, focusing on energy production and protection against oxidative stress. As a naturally occurring substance, ALA can be sourced from various foods or taken as a dietary supplement. The market's growth is fueled by increasing consumer interest in natural supplements, the pursuit of healthier lifestyles, and emerging research highlighting ALA's effectiveness in addressing various health conditions. Known for its skin health benefits, potential to lower oxidative stress, and support in glucose metabolism, ALA stands out due to its dual role as a fat- and water-soluble antioxidant. Available in diverse formats like liquids, tablets, and capsules, ALA is marketed both as a standalone product and within multi-ingredient formulas targeting specific health concerns.

Top-down and bottom-up approaches were used to estimate and validate the size of the Alpha Lipoic Acid market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Alpha Lipoic Acid Market Segments Analysis

Global Alpha Lipoic Acid Market is segmented by Product Type, Product Form, Distribution Channel, Application and region. Based on Product Type, the market is segmented into R Alpha Lipoic Acid and S Alpha Lipoic Acid. Based on Product Form, the market is segmented into Powder, Capsules, Tablets and Others. Based on Distribution Channel, the market is segmented into Direct sales, Indirect sales, Supermarkets, Departmental Stores, Retailers and Others. Based on Application, the market is segmented into Dietary Supplements, Cosmetics, Pharmaceuticals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Alpha Lipoic Acid Market

The alpha lipoic acid (ALA) market is significantly driven by its renowned antioxidant properties, which enable it to effectively identify and neutralize free radicals that may inflict cellular damage. As awareness about these beneficial qualities grows, there has been a notable increase in consumer demand for dietary supplements infused with alpha lipoic acid. Many consumers are actively seeking products that not only enhance overall health but also serve as a preventive measure against chronic diseases and help manage oxidative stress. This rising interest in ALA supplements reflects a broader trend toward health optimization and wellness-focused lifestyles.

Restraints in the Alpha Lipoic Acid Market

The alpha lipoic acid market faces significant restraints due to the limited awareness among consumers and healthcare professionals regarding its advantages and applications. This lack of knowledge hinders the recognition and uptake of ALA, preventing it from receiving the attention it warrants. To overcome this obstacle, it is essential to implement educational initiatives aimed at both patients and medical practitioners, focusing on the benefits of ALA and its proper usage. By addressing this information gap, the market could experience enhanced growth as more individuals become informed about the potential of alpha lipoic acid and its applications in health and wellness.

Market Trends of the Alpha Lipoic Acid Market

The Alpha Lipoic Acid (ALA) market is witnessing a significant upward trend driven by the rising demand for nutraceuticals and dietary supplements. As health awareness intensifies among consumers, there is an increasing inclination towards products that offer multifaceted health benefits, particularly in metabolic wellness and antioxidant support. ALA is celebrated for its antioxidant properties and its role in various health facets, prompting manufacturers to incorporate it into diverse functional foods and supplements. This growing consumer preference for health-enhancing products is propelling the ALA market forward, reflecting a broader trend towards preventive healthcare and holistic wellness solutions.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Alpha Lipoic Acid Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • R Alpha Lipoic Acid
  • S Alpha Lipoic Acid

Global Alpha Lipoic Acid Market Size by Product Form & CAGR (2025-2032)

  • Market Overview
  • Powder
  • Capsules
  • Tablets
  • Others

Global Alpha Lipoic Acid Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Direct sales
  • Indirect sales
  • Supermarkets
  • Departmental Stores
  • Retailers
  • Others

Global Alpha Lipoic Acid Market Size by Application & CAGR (2025-2032)

  • Market Overview
  • Dietary Supplements
  • Cosmetics
  • Pharmaceuticals
  • Others

Global Alpha Lipoic Acid Market Size & CAGR (2025-2032)

  • North America (Product Type, Product Form, Distribution Channel, Application)
    • US
    • Canada
  • Europe (Product Type, Product Form, Distribution Channel, Application)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Product Form, Distribution Channel, Application)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Product Form, Distribution Channel, Application)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Product Form, Distribution Channel, Application)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • NNB Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Avanscure Lifesciences (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Jiangsu Tohope Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Suzhou Fushilai Pharmaceutical Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cachet Pharmaceuticals Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biocon Limited (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Woerwag Pharma GmbH & Co. KG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tonghe (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shyndec (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fushilai Pharmaceutical (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Maidesen (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Taike Biological (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DKY Technology (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Haoxiang Bio (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Infa Group (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sudarshan Pharma (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Superior Supplement Manufacturing (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Supreem Pharmaceuticals Mysore Pvt. Ltd. (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Valence Labs (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Xian Tian Guangyuan Biotech (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations